Primary or secondary prevention of HIV-associated histoplasmosis during the early antiretrovirals for all era.
Main Authors: | Mathieu Nacher, Paul Le Turnier, Philippe Abboud, Ugo Françoise, Aude Lucarelli, Magalie Demar, Félix Djossou, Loïc Epelboin, Pierre Couppié, Antoine Adenis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-02-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0011066 |
Similar Items
-
Establishing the proportion of severe/moderately severe vs mild cases of progressive disseminated histoplasmosis in patients with HIV.
by: Mathieu Nacher, et al.
Published: (2022-11-01) -
Development of a case fatality prognostic score for HIV-associated histoplasmosis
by: Ugo Françoise, et al.
Published: (2023-07-01) -
Risk Factors for Mortality among HIV-Infected Patients with Disseminated Histoplasmosis
by: Mathieu Nacher, et al.
Published: (2020-11-01) -
Disseminated Histoplasmosis in HIV-Infected Patients: A Description of 34 Years of Clinical and Therapeutic Practice
by: Mathieu Nacher, et al.
Published: (2020-09-01) -
A Simple Predictive Score to Distinguish between Disseminated Histoplasmosis and Tuberculosis in Patients with HIV
by: Mathieu Nacher, et al.
Published: (2021-12-01)